ALFA FinderBSE filing, BSE: 542678. Summary written from the filing by ALFA Finder's alert engine.
Cian Healthcare Ltd: key numbers
- Share price
- ₹36.95
- Market cap
- ₹92.38 Cr
- Revenue (annual)
- ₹28.30 Cr
- Net profit (annual)
- ₹-23.29 Cr
- Promoter holding
- 95.00%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cian Healthcare Ltd
All →Cian Healthcare Employee Stock Options
Cian Healthcare granted 2,00,000 employee stock options at Rs 15 each on 4 November 2026. Options vest after one year, exercisable for five years thereafter.
Cian Healthcare Merger & Restructuring
Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.
Cian Healthcare Insolvency Petition
Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.
Cian Healthcare Other Announcement
Cian Healthcare filed its quarterly shareholding pattern. The company disclosed it is working to restore public shareholding levels following an NCLT-approved resolution plan.
Cian Healthcare Management Change
Cian Healthcare Limited has appointed M/s. Rasool Singhal & Co. as the new Statutory Auditor for a term of 60 months.
Cian Healthcare Annual General Meeting
Cian Healthcare Ltd held its 23rd AGM on September 29, 2026, approving financial statements, director re-appointment, auditor appointment, and the 2026 Employee Stock Option Scheme.
Other board meeting date announcements
All →Arvaya Healthcare Board Meeting Date
Arvaya Healthcare Ltd intimated a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
Aspire & Innovative Advertising Board Meeting Date
Aspire & Innovative Advertising scheduled a November 14, 2026 board meeting to consider unaudited standalone results for the half year ended September 30, 2026. No results figures are attached yet.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.
FlySBS Aviation Board Meeting Date
FlySBS Aviation has scheduled a board meeting for 11 November 2026 to consider unaudited half-yearly results for the period ended September 2026. The trading window is not closed.
Shri Krishna Devcon Board Meeting Date
Shri Krishna Devcon informs BSE of a board meeting on 14 November 2026 to consider quarterly and half-year unaudited results. The trading window stays closed until 48 hours after results are declared.